ARCHIVES

COG Begins Phase III Trial To Prevent Hearing Loss

This article is from The Cancer Letter archive.

Vol. 31 No. 5 | May 30, 2008

Download PDF Visit The Full Archive

Related Articles

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

October 29, 2010

Foundation Gives $1 Million To UPCI For Genetics Chair

December 13, 2002

John Niederhuber Named Acting NCI Director.

June 2, 2006

NCCS Networker Volume 1 Issue 3, Fall 1987

September 13, 1987

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004